OTC Medicines Archives | Page 2 of 65 | PAGB

Membership

We are the only trade association representing the interests of manufacturers of branded OTC medicines, self-care medical devices and food supplements in the UK.

Learn more

PAGB Align with MHRA Statement Confirming No Link Between Paracetamol Use in Pregnancy and Autism

PAGB has aligned with the MHRA's recent statement affirming that there is no evidence linking paracetamol use during pregnancy to autism in children, reinforcing its safety when used appropriately.

CMDh July 2025 Meeting – Minutes

The Co-ordination group for Mutual recognition and Decentralised procedures – human (CMDh) has published the minutes from their meeting held on 22-23 July 2025.

EMA Webinar – Revised Environmental Risk Assessment – 1 year experience

EMA is hosting a webinar on 'Environmental Risk Assessment' on Monday 6 October from 1.30pm to 4.00pm (GMT). This webinar will cover the one year experience with the revised guideline.

CMDh September 2025 Meeting – Report

The Co-ordination group for Mutual recognition and Decentralised procedures – human (CMDh) has published the report from the CMDh meeting held on 16-18 September 2025.

Get the most out of your PAGB membership – join our next session!

Join PAGB's upcoming Making the most of your membership session on 15 October to get an overview of our services, support and how best to access each service.

Updated EU Variations Guidelines Published

The European Commission has published updated guidelines on marketing authorisation variations, aligning with the 2024 amendment to the Variations Regulation. These new rules will take effect from 15 January 2026.

MHRA Marketing Authorisations Granted 1 to 14 September 2025

MHRA granted 3 OTC licences during 1 - 14 September 2025.

MHRA Performance Data – August 2025

MHRA has published its performance data for August 2025.

10-Year Health Plan – Free Webinar on How MHRA and NICE Will Bring Medicines to Patients Months Sooner

Free webinar about how the collaboration between MHRA and NICE will bring medicines to patients sooner.

MHRA & Department for Education Embed Medicine Safety Into School Curriculum

The importance of medicine safety and how to report side effects of medicines via the Yellow Card scheme is now part of the statutory guidance for schools in England.

MHRA Blog – Looking to Our Future: Reflections on the Strategic Choices Ahead for the MHRA

MHRA is publishing a series of blogs on the challenges and opportunities ahead. In the first instalment, Chief Executive Lawrence Tallon reflects on the changing healthcare landscape, the regulator’s role, and the priorities shaping the agency’s future direction.

DHSC Public Appointments

The Department of Health and Social Care (DHSC) has published information about non-executive appointments to DHSC's public bodies and committees in September 2025.